| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.05 |